These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6283817)

  • 1. Benzo(a)pyrene metabolism and enterohepatic circulation in the rat.
    Chipman JK; Hirom PC; Frost GS; Millburn P
    Adv Exp Med Biol; 1981; 136 Pt A():761-8. PubMed ID: 6283817
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of the 11,12-diol as a metabolite of benzo(a)pyrene by rat skin in vivo.
    Weston A; Grover PL; Sims P
    Biochem Biophys Res Commun; 1982 Apr; 105(3):935-41. PubMed ID: 6284170
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a 6-fluoro substituent on the metabolism and biological activity of benzo(a)pyrene.
    Buhler DR; Unlü F; Thakker DR; Slaga TJ; Conney AH; Wood AW; Chang RL; Levin W; Jerina DM
    Cancer Res; 1983 Apr; 43(4):1541-9. PubMed ID: 6299523
    [No Abstract]   [Full Text] [Related]  

  • 4. A fluorometric-HPLC assay for quantitating the binding of benzo[a]pyrene metabolites to DNA.
    Rahn RO; Chang SS; Holland JM; Shugart LR
    Biochem Biophys Res Commun; 1982 Nov; 109(1):262-8. PubMed ID: 6297478
    [No Abstract]   [Full Text] [Related]  

  • 5. Microsomal metabolism of 4-(N,N-diacetylamino)benzo[a]pyrene: a potent mutagenic arylamide derived from a carcinogenic polycyclic aromatic hydrocarbon.
    Chou MW; Miller DW; Freeman JP; Fu PP
    Chem Res Toxicol; 1988; 1(2):115-22. PubMed ID: 2979718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules.
    Shu HP; Bymun EN
    Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent differences in the benzo[a]pyrene-DNA adducts present in cell cultures from different species.
    Baird WM; Dumaswala RU; Diamond L
    Basic Life Sci; 1983; 24():565-86. PubMed ID: 6305334
    [No Abstract]   [Full Text] [Related]  

  • 9. Species heterogeneity in the metabolic processing of benzo[a]pyrene.
    Selkirk JK; MacLeod MC; Mansfield BK; Nikbakht PA; Dearstone KC
    Basic Life Sci; 1983; 24():283-94. PubMed ID: 6305329
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzo(a)pyrene metabolism by rat liver microsomes: effects of adding purified glutathione S-transferases A, B, and C.
    Morgenstern R; Guthenberg C; Mannervik B; DePierre JW; Ernster L
    Cancer Res; 1982 Oct; 42(10):4215-21. PubMed ID: 6286104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and enterohepatic circulation of benzo(a)pyrene-4,5-epoxide in the rat.
    Elmhirst TR; Chipman JK; Ribeiro O; Hirom PC; Millburn P
    Xenobiotica; 1985 Nov; 15(11):899-906. PubMed ID: 4082630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of UDP-glucuronosyltransferase in the inactivation of benzo(a)pyrene.
    Bock KW; Bock-Hennig BS; Lilienblum W; Pfeil H; Volp RF
    Adv Exp Med Biol; 1981; 136 Pt A():53-73. PubMed ID: 6283814
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of glucuronide, sulphate and glutathione conjugates of benzo[a]pyrene metabolites in hepatocytes isolated from inbred strains of mice.
    Zaleski J; Bansal SK; Gessner T
    Carcinogenesis; 1983 Nov; 4(11):1359-66. PubMed ID: 6315254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formation and persistence of benzo(a)pyrene metabolite-deoxyribonucleoside adducts in rat skin in vivo.
    Ashurst SW; Cohen GM
    Int J Cancer; 1981 Sep; 28(3):387-92. PubMed ID: 6274815
    [No Abstract]   [Full Text] [Related]  

  • 15. The biliary excretion and enterohepatic circulation of benzo(a)pyrene and its metabolites in the rat.
    Chipman JK; Hirom PC; Frost GS; Millburn P
    Biochem Pharmacol; 1981 May; 30(9):937-44. PubMed ID: 6263289
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic activation of benzo[a]pyrene in human skin maintained in short-term organ culture.
    Weston A; Grover PL; Sims P
    Chem Biol Interact; 1983 Aug; 45(3):359-71. PubMed ID: 6309420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 18. Arachidonic acid-dependent activation of benzo[a]pyrene to bind to proteins with cytosolic and microsomal fractions from rat liver and lung.
    Nemoto N; Takayama S
    Carcinogenesis; 1984 Jul; 5(7):961-4. PubMed ID: 6329541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of epoxide hydrolase activity; effect on the activation of benzo[a] pyrene and its covalent binding to DNA in the nucleus.
    Guenthner TM; Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():705-16. PubMed ID: 6283816
    [No Abstract]   [Full Text] [Related]  

  • 20. Inter-individual differences in oxidative benzo(a)pyrene metabolism by normal and tumorous surgical lung specimens from 105 lung cancer patients.
    Sabadie N; Richter-Reichhelm HB; Saracci R; Mohr U; Bartsch H
    Int J Cancer; 1981; 27(4):417-25. PubMed ID: 6268552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.